Flyer

Journal of Biomedical Sciences

  • ISSN: 2254-609X
  • Journal h-index: 18
  • Journal CiteScore: 4.95
  • Journal Impact Factor: 4.78
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Google Scholar
  • SHERPA ROMEO
  • Secret Search Engine Labs
Share This Page

Mini Review - (2023) Volume 12, Issue 3

Stem Cell Behavior in Cancer

Holland J Scott*
 
Faculty of Veterinary Medicine, Ghent University, 9820 ,Merelbeke, Belgium
 
*Correspondence: Holland J Scott, Faculty of Veterinary Medicine, Ghent University, 9820 ,Merelbeke, Belgium, Email:

Received: 03-Apr-2023, Manuscript No. ipjbs-23-13696; Editor assigned: 05-Apr-2023, Pre QC No. P-23-13696; Reviewed: 19-Apr-2023, QC No. Q-23-13696; Revised: 22-Apr-2023, Manuscript No. R-23-13696; Published: 31-May-2023

Abstract

The body's proper operation and maintenance depend on stem cells. Undesirable ways of behaving can debilitate the insusceptible framework, making people more defenceless to contaminations and different infections. Unhealthy behaviors contribute to mental health conditions like anxiety and depression, which can have a significant impact on mental health. Stem cells contribute to the repair and regeneration of damaged tissues in healthy individuals, ensuring that organs and tissues function normally. Tumor initiation, progression, and resistance to therapy all depend on cancer stem cells (CSCs). CSCs' uncontrolled self-renewal and differentiation may result in the development of tumors and the body-wide spread of cancer. CSCs are impervious to traditional disease treatments like chemotherapy and radiation, prompting backslide and unfortunate therapy results. Studies have shown that CSCs can suppress immune responses, resulting in a weakened immune system and increased susceptibility to infections. This behavior of CSCs can affect the immune system. Age-related diseases like Alzheimer's and Parkinson's can develop as a result of stem cell dysfunction, which can result in a decline in tissue regeneration and repair. For the development of new therapies that target CSCs and improve treatment outcomes, it is essential to have an understanding of the mechanisms that regulate the behavior of stem cells. The treatment of a variety of diseases could be completely transformed by therapies that are based on stem cells. However, stem cell-based therapies' limitations and risks must be carefully evaluated and monitored. New approaches to stem cell-based therapies that minimize risks and maximize benefits are currently being investigated. Stem cell health and overall health outcomes can be improved through lifestyle changes like eating a healthy diet, exercising regularly, and reducing stress. All in all, the way of behaving of undeveloped cells, especially CSCs, can fundamentally affect the body, prompting the turn of events and movement of malignant growth, debilitated resistant framework, and age-related illnesses.

Keywords

Stem cells; Cancer stem cells; Immune system; Regenerative medicine; Age-related diseases

Introduction

Undifferentiated stem cells are capable of self-renewal and differentiation into various cell types. The development and maintenance of the body's tissues and organs are greatly aided by stem cells. Undeveloped cells can possibly be utilized for regenerative medication, giving new medicines to different sicknesses. However, stem cell behavior can also play a role in the onset and progression of diseases like cancer. A small number of cells in a tumor that resemble stem cells are called cancer stem cells (CSCs). Tumor initiation, progression, and resistance to treatment all depend heavily on CSCs. The immune system may be impacted by CSC behavior, resulting in a diminished immune response and increased susceptibility to infections. Dysfunction in stem cells can also be a factor in age-related diseases like Parkinson's and Alzheimer's. In order to improve treatment outcomes and develop new treatments that target CSCs, it is essential to comprehend the mechanisms that regulate the behavior of stem cells. Stem cell health and overall health outcomes can also be improved through healthy habits like regular exercise and stress reduction. Immature microorganism based treatments can possibly reform medication, yet the likely dangers and impediments should be painstakingly assessed. New treatments for a variety of diseases, including autoimmune conditions and blood disorders, have emerged as a result of recent advances in stem cell research. Stem cell-based treatments now have new possibilities thanks to the development of cutting-edge technologies like gene editing and induced pluripotent stem cells (iPSCs). For stem cell-based therapies to be safe and effective, regulatory agencies like the FDA must regulate them [1, 2].

DISCUSSION

Stem cells are a distinct class of cells that are capable of self-renewal and differentiation into various body cell types. Their dysfunction can result in a variety of diseases, including cancer, and they play a crucial role in the maintenance and regeneration of tissue [3]. Cancer is a complicated condition that develops when abnormal cells in the body grow and divide out of control. It is presently generally acknowledged that malignant growth foundational microorganisms (CSCs) assume a basic part in cancer commencement, movement, and protection from treatment. In this article, we will discuss how cancer alters the behavior of stem cells. A small number of cells in the tumor that resemble stem cells are called cancer stem cells [4]. They are capable of self-renewal, differentiation into a variety of cell types, and beginning the growth of tumors. Tumors are thought to be resistant to conventional cancer treatments like chemotherapy and radiation because of CSCs. CSCs can self-renew and differentiate uncontrollably, resulting in the formation of tumors, in contrast to normal stem cells, which are tightly controlled and maintained by the microenvironment. A few variables add to the way of behaving of undifferentiated cells during disease. The tumor microenvironment is one of the most crucial aspects. A complex network of cells and extracellular matrix components that surround the tumor is the tumor's microenvironment. It gives flags that control the way of behaving of CSCs, including their self-reestablishment, separation, and endurance. Low oxygen levels, high levels of reactive oxygen species (ROS), and a broken extracellular matrix are the hallmarks of the tumor microenvironment. The stemness of CSCs and their resistance to therapy may be aided by these conditions. The activation of signaling pathways is another factor that influences how stem cells behave during cancer. CSCs frequently activate a number of signaling pathways, including Wnt, Notch, and Hedgehog. Cancer frequently destabilizes these pathways, which control the self-renewal and differentiation of stem cells. The initiation of these pathways can advance the stemness of CSCs and their protection from treatment. Epigenetic changes also influence how stem cells behave during cancer. Epigenetic changes allude to alterations to DNA and histones that direct quality articulation. Stem cell behavior can be altered by these changes, which can also help cancer grow and spread. DNA methylation and histone modifications, for instance, can activate oncogenes and silence tumor suppressor genes, transforming healthy cells into cancer cells [5, 6].

The complex network of cells and extracellular matrix components that surround a tumor is referred to as the tumor microenvironment. It is made up of stromal cells, endothelial cells, cancer cells, immune cells, stromal cells, and extracellular matrix components like collagen and fibronectin. Important signals that regulate tumor growth, invasion, and metastasis are provided by the tumor microenvironment. It is likewise described by low oxygen levels, elevated degrees of receptive oxygen species, and an upset extracellular framework, which can advance growth movement and protection from treatment. New cancer therapies that target the tumor microenvironment and improve treatment outcomes require an understanding of the tumor micro-environment [7, 8].

The behavior of stem cells can have a significant impact on the body's overall health, and they are necessary for the body's proper operation and upkeep. Stem cells contribute to the repair and regeneration of damaged tissues in healthy individuals, ensuring that organs and tissues function normally. Nonetheless, on account of malignant growth, the way of behaving of disease undeveloped cells (CSCs) can fundamentally affect the body. Within a tumor, CSCs are a small population of cells that resemble stem cells and play a crucial role in tumor initiation, progression, and therapy resistance. CSCs' uncontrolled self-renewal and differentiation may result in the development of tumors and the body-wide spread of cancer. Additionally, it has been demonstrated that CSCs are resistant to standard cancer treatments like chemotherapy and radiation, which can result in relapse and poor treatment outcomes. Studies have shown that CSCs can suppress immune responses, resulting in a weakened immune system and increased susceptibility to infections. This behavior of CSCs can also affect the immune system. Moreover, on-going examination has recommended that the way of behaving of undeveloped cells might assume a part in the improvement old enough related sicknesses like Alzheimer's and Parkinson's illness. These conditions can emerge as a result of the decline in tissue repair and regeneration caused by stem cell dysfunction [9, 10].

CONCLUSION

During cancer, the behavior of stem cells changes, which contributes to the disease's development and progression. Tumor initiation, progression, and resistance to treatment all depend heavily on CSCs. Stem cell behavior is influenced by the tumor microenvironment, signaling pathways, and epigenetic changes during cancer. For the development of new therapies that target CSCs and improve the outcomes of cancer treatment, it is essential to comprehend the mechanisms that regulate stem cell behavior during cancer. The behavior of stem cells, especially CSCs, can have a significant impact on the body, accelerating the onset and progression of cancer, weakened immune systems, and age-related diseases. For the development of new therapies that target CSCs and improve treatment outcomes, it is essential to have an understanding of the mechanisms that regulate the behavior of stem cells. Understanding the way of behaving of undeveloped cells is critical for growing new medicines for different sicknesses and advancing generally speaking wellbeing and prosperity. The way of behaving of immature microorganisms assumes a basic part in keeping up with the general wellbeing and prosperity of a person. Undeveloped cells can possibly be utilized for regenerative medication, giving new medicines to different sicknesses. However, the behavior of cancer stem cells (CSCs) can also contribute to the growth and spread of cancer, weaken the immune system, and have negative health effects. Dysfunction in stem cells can also be a factor in age-related diseases like Parkinson's and Alzheimer's. Therefore, developing new treatments that target CSCs and improve treatment outcomes requires an understanding of the mechanisms that regulate stem cell behavior. Stem cell health and overall health outcomes can also be improved through healthy habits like regular exercise and stress reduction. New treatments for a variety of diseases have emerged as a result of recent advances in stem cell research, but the potential dangers and drawbacks of stem cell-based therapies must be carefully evaluated and monitored. We can open the door to a new era in regenerative medicine by regulating therapies based on stem cells and guaranteeing their safety and effectiveness.

ACKNOWLEDGMENT

None

CONFLICT OF INTEREST

No conflict of interest to declare about this work.

REFERENCES

  1. Tomlin JL, Sturgeon C, Pead MJ, et al. Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs. Vet Rec.2000;147(2): 129-32.
  2. Indexed at, Google Scholar, Crossref

  3. Psychas V, Loukopoulos P, Polizopoulou ZS, et al. Multilobular tumour of the caudal cranium causing severe cerebral and cerebellar compression in a dog. J Vet Sci. 2009; 10(5): 81-3.
  4. Indexed at, Google Scholar, Crossref

  5. Loukopoulos P, Thornton JR, Robinson WF. Clinical and pathologic relevance of p53 index in canine osseous tumors. Veterinary Pathology.2003; 40(8): 237-48.
  6. Indexed at, Google Scholar, Crossref

  7. Bech-Nielsen S, Haskins ME. Frequency of osteosarcoma among first-degree relatives of St Bernard dogs. J Natl Cancer Inst.2003;60(4): 349-53.
  8. Indexed at, Google Scholar, Crossref

  9. Wilkins RM, Cullen JW, Odom L. Superior survival in treatment of primary nonmetastatic pediatric osteosarcoma of the extremity. Ann Surg Oncol.2003; 10(4): 498-507.
  10. Indexed at, Google Scholar, Crossref

  11. Kundu ZS. Classification, imaging, biopsy and staging of osteosarcoma. Indian J Orthop.2014;48(2): 238-46.
  12. Indexed at, Google Scholar, Crossref

  13. Papalas JA, Balmer NN, Wallace C. Ossifying dermatofibroma with osteoclast-like giant cells: report of a case and literature review. Am J Dermatopathol.2009; 31(5): 379-83.
  14. Indexed at, Google Scholar, Crossref

  15. Gelberg KH, Fitzgerald EF, Hwang SA. Fluoride exposure and childhood osteosarcoma: a case-control study. Am J Public Health.1995; 85(2): 1678-83.
  16. Indexed at, Google Scholar, Crossref

  17. Luetke A, Meyers PA, Lewis A. Osteosarcoma treatment where do we stand a state of the art review. Cancer Treat Rev. 2014; 40(5): 523-532.
  18. Indexed at, Google Scholar, Crossref

  19. Dhaliwal J, Sumathi VP, Grimer RJ. Radiation-induced periosteal osteosarcoma (PDF). Grand Rounds.2009;10(1): 13-18.
  20. Indexed at, Google Scholar, Crossref